{"id":"https://openalex.org/W2414672467","doi":null,"title":"[Neuron-specific enolase (NSE) serum level as a prognostic factor in non-small cell lung cancer].","display_name":"[Neuron-specific enolase (NSE) serum level as a prognostic factor in non-small cell lung cancer].","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2414672467","mag":"2414672467","pmid":"https://pubmed.ncbi.nlm.nih.gov/12518626"},"language":"pl","primary_location":{"id":"pmid:12518626","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12518626","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pneumonologia i alergologia polska","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112244087","display_name":"Jacek Zych","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134575","display_name":"Instytut Gru\u017alicy i Chor\u00f3b P\u0142uc","ror":"https://ror.org/0431cb905","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210134575"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Jacek Zych","raw_affiliation_strings":["Instytut Gru\u017alicy i Chor\u00f3b P\u0142uc w Warszawie"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instytut Gru\u017alicy i Chor\u00f3b P\u0142uc w Warszawie","institution_ids":["https://openalex.org/I4210134575"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031159327","display_name":"Monika Szturmowicz","orcid":"https://orcid.org/0000-0002-5625-6051","observed_orcids":["https://orcid.org/0000-0002-5625-6051"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monika Szturmowicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027814799","display_name":"Anna Sakowicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Sakowicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012564000","display_name":"J S\u0142odkowska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janina S\u0142odkowska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112143741","display_name":"Monika Za\u0142\u0119ska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monika Za\u0142eska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091427878","display_name":"El\u017cbieta Radzikowska","orcid":"https://orcid.org/0000-0002-2585-8594","observed_orcids":["https://orcid.org/0000-0002-2585-8594"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elzbieta Radzikowska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014236016","display_name":"Jolanta Za\u0142\u0119ska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jolanta Za\u0142eska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034083838","display_name":"Zbigniew Jodkiewicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zbigniew Jodkiewicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019348253","display_name":"Ewa Rowinska-Zakrzewska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ewa Rowi\u0144ska-Zakrzewska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.3478488,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"70","issue":"5-6","first_page":"278","last_page":"83"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.725600004196167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.725600004196167,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.26930001378059387,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuron-specific-enolase","display_name":"neuron-specific enolase","score":1.0},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.675000011920929},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cisplatin-based-chemotherapy","display_name":"cisplatin-based chemotherapy","score":0.8799999952316284},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.7289999723434448},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.5759999752044678},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.8989999890327454},{"id":"https://openalex.org/keywords/inoperable-lung-cancer","display_name":"inoperable lung cancer","score":0.8009999990463257},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.8859999775886536},{"id":"https://openalex.org/keywords/vinblastine","display_name":"vinblastine","score":0.9739999771118164},{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.948495626449585},{"id":"https://openalex.org/C2777132456","wikidata":"https://www.wikidata.org/wiki/Q282629","display_name":"Vinblastine","level":3,"score":0.8492340445518494},{"id":"https://openalex.org/C188618488","wikidata":"https://www.wikidata.org/wiki/Q24776639","display_name":"Enolase","level":3,"score":0.7647168040275574},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.7599427700042725},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7090973854064941},{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.6858921051025391},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6783802509307861},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6372944712638855},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5965244770050049},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.589898407459259},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.4487364888191223},{"id":"https://openalex.org/C3019864225","wikidata":"https://www.wikidata.org/wiki/Q5867482","display_name":"Combination chemotherapy","level":3,"score":0.420238733291626},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.41036325693130493},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4018576741218567},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.11055910587310791}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010751","descriptor_name":"Phosphopyruvate Hydratase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011044","descriptor_name":"Poland","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014751","descriptor_name":"Vindesine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12518626","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12518626","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pneumonologia i alergologia polska","raw_type":"English Abstract"},{"id":"mag:2414672467","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12518626","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2405809110","https://openalex.org/W2428863551","https://openalex.org/W2401730402","https://openalex.org/W2512529919","https://openalex.org/W2363897974","https://openalex.org/W7208087871","https://openalex.org/W3120225221","https://openalex.org/W2381887767","https://openalex.org/W2091822425","https://openalex.org/W2045062690"],"abstract_inverted_index":{"The":[0,26],"aim":[1],"of":[2,10,42,46,53,55,70,166],"the":[3,8,51,156,185],"study":[4],"was":[5,33,122,144,152,171],"to":[6,21,62,163],"assess":[7],"significance":[9],"elevated":[11,39,128,190],"NSE":[12,27,43,129,139,191],"serum":[13,28,40,130,140,164,192],"level":[14,29,41,131,141,165],"in":[15,44,111,124,134,187,198],"NSCLC":[16],"patients":[17,48,73,82,126,136,175,188],"for":[18,24,155],"tumor":[19,186],"response":[20,109,121],"chemotherapy":[22],"and":[23,67,99,110,142,173],"survival.":[25,205],"above":[30],"12.5":[31],"mg/l":[32],"regarded":[34],"as":[35],"elevated.":[36],"We":[37,181],"found":[38,117],"71":[45],"146":[47],"(48.6%)":[49],"at":[50],"time":[52,151],"diagnosis":[54],"inoperable":[56],"non-small":[57],"cell":[58],"lung":[59],"cancer,":[60],"independently":[61],"age,":[63],"sex,":[64],"performance":[65],"status":[66],"histological":[68],"type":[69],"cancer.":[71],"All":[72],"were":[74,83,116],"treated":[75,84],"using":[76],"cisplatin":[77],"based":[78],"combination":[79],"chemotherapy.":[80,119],"44":[81],"with":[85,90,95,101,127,137,159,189],"cisplatin/etoposide":[86],"(group":[87,92,97,103],"PE),":[88],"37":[89],"cisplatin/vinblastine":[91],"PV),":[93],"20":[94],"cisplatin/vinorelbine":[96],"PN)":[98],"58":[100],"cisplatin/etoposide/vinblastine":[102],"PEV)":[104],"combination.":[105],"In":[106],"26.7%":[107],"partial":[108],"another":[112],"21.2%":[113],"minimal":[114],"regression":[115],"after":[118],"Partial":[120],"observed":[123],"38%":[125],"but":[132],"only":[133],"16%":[135],"normal":[138],"difference":[143,161],"significant":[145],"(p":[146],"=":[147],"0.0153).":[148],"Median":[149],"survival":[150,169],"8.5":[153],"months":[154],"whole":[157],"group":[158],"no":[160],"according":[162],"NSE.":[167],"One-year":[168],"rate":[170],"29%":[172],"9":[174],"survived":[176],"24":[177],"month":[178],"or":[179],"more.":[180],"conclude":[182],"that":[183],"although":[184],"levels":[193],"regress":[194],"more":[195],"frequently":[196],"than":[197],"others":[199],"it":[200],"does":[201],"not":[202],"influence":[203],"their":[204]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}